Update on Dry AMD, Gene testing for Glaucoma, Preserflo for IOP Control & Interesting Live Patient Cases
Date: 18/06/2024 (AEST)
Venue: 302 Bourbong Street, Bundaberg West, QLD, 4670
Provider: Bundaberg Eye Clinic
Contact: Rachael Brady, [E] manager@bundabergeye.com.au, [P] 07 4153 4490
Activity Outline
Discussion of Pegcetacoplan and its use in Atrophic Age Related Macular Degeneration by outlining mode of action, administration and purpose of treatment.
Discussion of Seonix Glaucoma gene testing in patients - primary purpose and benefits of gene testing for glaucoma risk.
Discussion of Preserflo for IOP control when drops fail - benefits of treatment, mode of action.
Interesting live patient cases for examination and discussion.
Learning Objectives
- Understand what condition Pegcetacoplan is used to treat and the purpose of treatment
- Understand the mode of action and side effects of Pegcetacoplan at the end of the session
- Understand the role of genetic testing in glaucoma and the benefits of gene testing for health care providers
- Understand what type of genetic material is analysed and how this is obtained for sampling
- Understand the use of Preserflo in glaucoma and IOP control
- Understand how Preserflo is inserted into the eye and the key benefits of using Preserflo in glaucoma surgery
- Examine live patients with interesting conditions and diagnose the presenting condition along with formulating a patient treatment plan based on self-diagnosis of presenting condition
Max CPD hours awarded: 3
Session Information
| Name |
|---|
| Pegcetacoplan and Dry Macular Degeneration |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |
| Name |
|---|
| Gene Testing for glaucoma risk |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |
| Name |
|---|
| Preserflo for IOP control |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |
| Name |
|---|
| Interesting Live Cases |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |